Anitha G, Nagaraj M, Jayashree A Comparative evaluation of levels of C-reactive protein and PMN in periodontitis patients related to cardiovascular disease. J Indian Soc Periodontol. 2013 May;17(3):330-2. doi: 10.4103/0972-124X.115657.
Bokhari SA, Khan AA, Butt AK, Azhar M, Hanif M, Izhar M, Tatakis DN Non-surgical periodontal therapy reduces coronary heart disease risk markers: a randomized controlled trial. J Clin Periodontol. 2012 Nov;39(11):1065-74. doi: 10.1111/j.1600-051X.2012.01942.x. Epub 2012 Sep 11.
Carter K, Landini G, Walmsley AD Automated quantification of dental plaque accumulation using digital imaging. J Dent. 2004 Nov;32(8):623-8.
Chen T, Yu WH, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database (Oxford). 2010 Jul 6;2010:baq013. doi: 10.1093/database/baq013.
Cusumano CA Periodontal disease associated with an increased CRP in chronic hemodialysis patients. Rev Nefrol Dial Trans. 2013; 33:188-195.
de Oliveira C, Watt R, Hamer M Toothbrushing, inflammation, and risk of cardiovascular disease: results from Scottish Health Survey. BMJ. 2010 May 27;340:c2451. doi: 10.1136/bmj.c2451.
Goyal L, Bey A, Gupta ND, Sharma VK Comparative evaluation of serum C-reactive protein levels in chronic and aggressive periodontitis patients and association with periodontal disease severity. Contemp Clin Dent. 2014 Oct;5(4):484-8. doi: 10.4103/0976-237X.142816.
Gundala R, Chava VK Effect of lifestyle, education and socioeconomic status on periodontal health. Contemp Clin Dent. 2010 Jan;1(1):23-6. doi: 10.4103/0976-237X.62516.
Kholy KE, Genco RJ, Van Dyke TE Oral infections and cardiovascular disease. Trends Endocrinol Metab. 2015 Jun;26(6):315-21. doi: 10.1016/j.tem.2015.03.001. Epub 2015 Apr 16. Review.
Kim HC, Yang DM, Lee CM, Jin W, Nam DH, Song JY, Kim JY Acute appendicitis: relationships between CT-determined severities and serum white blood cell counts and C-reactive protein levels. Br J Radiol. 2011 Dec;84(1008):1115-20. doi: 10.1259/bjr/47699219. Epub 2010 Dec 1.
Kim YH, Lee SY Identification of non-streptococcal organisms from human dental plaque grown on the Streptococcus-selective medium mitis-salivarius agar. Arch Oral Biol. 2015 Feb;60(2):267-71. doi: 10.1016/j.archoralbio.2014.11.002. Epub 2014 Nov 8.
Kumar KR, Ranganath V, Naik R, Banu S, Nichani AS Assessment of high-sensitivity C-reactive protein and lipid levels in healthy adults and patients with coronary artery disease, with and without periodontitis--a cross-sectional study. J Periodontal Res. 2014 Dec;49(6):836-44. doi: 10.1111/jre.12172. Epub 2014 Mar 12.
Loos BG Systemic markers of inflammation in periodontitis. J Periodontol. 2005 Nov;76(11 Suppl):2106-15. Review.
Mani A, Vadvadgi V, Anarthe R, Saini R, Mani S A clinical study on Dental Air Force Cleaning System on adult chronic periodontits and its assessment to C-reactive protein levels. Int J Exp Dent Sci. 2012; 1:14-18.
Mbawalla HS, Masalu JR, Astrøm AN Socio-demographic and behavioural correlates of oral hygiene status and oral health related quality of life, the Limpopo-Arusha school health project (LASH): a cross-sectional study. BMC Pediatr. 2010 Nov 30;10:87. doi: 10.1186/1471-2431-10-87.
Pejcic A, Kesic LJ, Milasin J C-reactive protein as a systemic marker of inflammation in periodontitis. Eur J Clin Microbiol Infect Dis. 2011 Mar;30(3):407-14. doi: 10.1007/s10096-010-1101-1. Epub 2010 Nov 6.
Persson GR, Persson RE Cardiovascular disease and periodontitis: an update on the associations and risk. J Clin Periodontol. 2008 Sep;35(8 Suppl):362-79. doi: 10.1111/j.1600-051X.2008.01281.x. Review.
Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997 Apr 3;336(14):973-9. Erratum in: N Engl J Med 1997 Jul 31;337(5):356.
Ridker PM, Hennekens CH, Buring JE, Rifai N C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000 Mar 23;342(12):836-43.
Short VL, Ivory-Walls T, Smith L, Loustalot F The Mississippi Delta Cardiovascular Health Examination Survey: Study Design and Methods. Epidemiol Res Int. 2014 Jan 1;2014(Article 499 861461):861461.
Tonetti MS Periodontitis and risk for atherosclerosis: an update on intervention trials. J Clin Periodontol. 2009 Jul;36 Suppl 10:15-9. doi: 10.1111/j.1600-051X.2009.01417.x. Review.
Van Dyke TE, van Winkelhoff AJ Infection and inflammatory mechanisms. J Clin Periodontol. 2013 Apr;40 Suppl 14:S1-7. doi: 10.1111/jcpe.12088. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.